Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management (Q37039725)

17 August 2017

1 reference

title

Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management (English)

1 reference

polycystic ovary syndrome

17 August 2017

1 reference

1 reference

Farshchi H

1

1 reference

17 August 2017

Rane A

series ordinal

2

1 reference

17 August 2017

Love A

series ordinal

3

1 reference

17 August 2017

Kennedy RL

series ordinal

4

1 reference

17 August 2017

1 November 2007

1 reference

Journal of Obstetrics and Gynaecology

17 August 2017

1 reference

17 August 2017

27

1 reference

17 August 2017

8

1 reference

17 August 2017

762-773

1 reference

Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome.

17 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Reactive hypoglycemia in lean young women with PCOS and correlations with insulin sensitivity and with beta cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

The prevalence and features of the polycystic ovary syndrome in an unselected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Insulin resistance and metformin in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Effects of ghrelin on hypothalamic glucose responding neurons in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Serum sex hormone-binding globulin levels show too much variability to be used effectively as a screening marker for insulin resistance in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

The use of herbs and dietary supplements in gynecology: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Effects of insulin-induced hypoglycaemia on energy intake and food choice at a subsequent test meal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Stress in women: metabolic syndrome and polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Role of diet in the treatment of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Regular meal frequency creates more appropriate insulin sensitivity and lipid profiles compared with irregular meal frequency in healthy lean women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

A review of the metabolic effects of sibutramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

A randomized trial of a low-carbohydrate diet for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Metformin-diet benefits in women with polycystic ovary syndrome in the bottom and top quintiles for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Relative impact of insulin resistance and obesity on cardiovascular risk factors in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Polycystic ovary syndrome and endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Polycystic ovary syndrome and mental health: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Role of lifestyle modification in the management of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Effect of exercise duration and intensity on weight loss in overweight, sedentary women: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Treatment effect of sibutramine compared to fluoxetine on leptin levels in polycystic ovary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Nutrition in patients with Type 2 diabetes: are low-carbohydrate diets effective, safe or desirable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Meal and snack patterns are associated with dietary intake of energy and nutrients in US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Orexin a preferentially excites glucose-sensitive neurons in the lateral hypothalamus of the rat in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

The optimal diet for women with polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Polycystic ovary syndrome in adolescents: current and future treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Weight loss by bariatric surgery and subsequent fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Improving reproductive performance in overweight/obese women with effective weight management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Effect of a high-protein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Dietary and metabolic differences in pre- versus postmenopausal women taking or not taking hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Pathogenesis of polycystic ovary syndrome: what is the role of obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

A low-carbohydrate as compared with a low-fat diet in severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Polycystic ovarian syndrome and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Meal pattern, food choice, nutrient intake and lifestyle factors in The Göteborg Adolescence Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Do young women with polycystic ovary syndrome show early evidence of preclinical coronary artery disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Increase in daily LH secretion in response to short-term calorie restriction in obese women with PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Dietary fat, fatty acid composition in plasma and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Long-term health consequences of PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Decreased thermic effect of food after an irregular compared with a regular meal pattern in healthy lean women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Obesity and the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610701667338

10.1080/01443610701667338

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference